APP and Alzheimer disease: The protein level of β-secretase (BACE) in the RIPA soluble fraction from the hippocampus of J147-treated mice is significantly reduced compared to the untreated AD mice (Figure 2D) suggesting that J147 treatment down-regulated BACE, which is critical for APP cleavage that eventually gives rise to Aβ [47-51].